Value proposition

The essential biodata life science partner for rare and neurodegenerative diseases

CENTOGENE’s mission is to provide data-driven, life-changing answers to patients, physicians, and pharma companies for rare and neurodegenerative diseases. We integrate multiomic technologies with the CENTOGENE Biodatabank – providing dimensional analysis to guide the next generation of precision medicine. Our unique approach enables rapid and reliable diagnosis for patients, supports a more precise physician understanding of disease states, and accelerates and de-risks targeted pharma drug discovery, development, and commercialization.

Biochemical diagnostic test, Genetic diagnostic test, Rare diseases, Congenital diseases, Oncogenetics, Clinical and medical interpretation of genetic data, Next Generation Sequencing, Biomarker, covid19, Whole Exome Seguencing (WES), Whole Genome Sequencing (WGS), Clinical Studies, NGS Panels, Prenatal Testing, Single Gene, and SARS-CoV-2